NCT06820203 is a NA clinical trial of Fentanyl and Bupivacaine in Premixed, sponsored by Tanta University.

Who is sponsoring NCT06820203?

NCT06820203 is sponsored by Tanta University.

What drugs are being tested in NCT06820203?

Interventions in NCT06820203: Fentanyl and Bupivacaine, Fentanyl and Bupivacaine, Fentanyl and Bupivacaine.

What condition does NCT06820203 study?

NCT06820203 studies Premixed, Sequential, Manually Mixed, Intrathecal, Fentanyl, Bupivacaine, Cesarean Section.

Is NCT06820203 still recruiting?

NCT06820203 is currently completed. Last updated 25 July 2025.

Last reviewed 2025-07-25 · How we verify

NCT06820203

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Premixed, Sequential and Manually Mixed Administration of Intrathecal Fentanyl and Bupivacaine in Cesarean Section

Completed NA Last updated 25 July 2025

What this trial tests

NA trial testing Fentanyl and Bupivacaine in Premixed in 90 participants. Completed in 15 July 2025.

Timeline

12 February 2025

Primary endpoint
15 July 2025

15 July 2025

Quick facts

Lead sponsor	Tanta University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	90
Start date	12 February 2025
Primary completion	15 July 2025
Estimated completion	15 July 2025
Sites	1 location across Egypt

Drugs / interventions tested

Fentanyl and Bupivacaine — full drug profile →
Fentanyl and Bupivacaine — full drug profile →
Fentanyl and Bupivacaine — full drug profile →

Conditions studied

Premixed — all drugs for Premixed →
Sequential — all drugs for Sequential →
Manually Mixed — all drugs for Manually Mixed →
Intrathecal — all drugs for Intrathecal →

Sponsor

Tanta University

Who can join

Adults 18 to 40, female only, with Premixed or Sequential. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to distinguish between premixed, sequential, and manually mixed administration of intrathecal fentanyl and bupivacaine in cesarean section.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Tanta University trials

Trials by the same sponsor.

NCT07398651 — Apremilast and Adalimumab in Psoriatic Arthritis Patients · NA · not yet recruiting
NCT06966856 — This Randomized, Clinical Trial Evaluates the Efficacy of Oral Versus Sublingual Vitamin B12 Supplementation in Correcti · Phase 3 · not yet recruiting
NCT07334197 — Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy · NA · not yet recruiting
NCT07498998 — Glucocorticoid, Ozone and 5% Dextrose Local Injection for Pain Relief in Carpal Tunnel Syndrome · NA · not yet recruiting
NCT07114250 — Comparative Study Between Spinal Anesthesia Versus General Anesthesia in Supine Percutaneous Nephrolithotomy Operation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06820203 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tanta University
Last refreshed: 25 July 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06820203.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing